Abbott Laboratories (ABT)
# $195.09 Billion USD
Local Currency: $ 195.09 Billion
Company Details
-
Name
Abbott Laboratories
-
Symbol
ABT
-
Exchange
NYSE
-
Country
USA
-
Market Capitalization (USD)
$ 195.09 Billion
-
Market Capitalization in US Dollar
$ 195.09 Billion
-
Rank (Global)
62
-
Rank (Local)
41
-
Last Traded Price
$ 113.19
-
24h Change (%)
+0.78%
-
7-Day Change (%)
-0.22%
-
52-Week Range
Low: $99.60 | High: $119.39
-
All-Time Range
Low: $0.42 | High: $133.72
-
Shares Outstanding
1.73 Billion
-
Float Shares
1.72 Billion
-
Growth Rate (CAGR)
14.75%
-
Last Updated
14 Jan 2025, 16:50
Abbott Laboratories (ABT) - Market Cap & Rankings
Market Cap: $195.09 Billion ($195.09 Billion)
Global Rank: #62 | USA Rank: #41
Headquartered in USA, listed on NYSE
Market Cap & Net Worth: Abbott Laboratories (ABT)
As of January 2025, Abbott Laboratories (ABT)'s market cap is $195.09 Billion USD ($195.09 Billion). Abbott Laboratories is currently ranked #62 globally.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Abbott Laboratories's stock price ($113.19) by its total outstanding shares (1.73 Billion).
Abbott Laboratories's market cap data from 1984 to 2025 shows a compound annual growth rate (CAGR) of 14.75%.
Historical Market Cap (1984 - 2025)
Chart: Historical market capitalization in USD, 1984 - 2025
Year-by-Year Market Capitalization for Abbott Laboratories
Track Abbott Laboratories's market capitalization journey from 1984 to 2025. The company's current market cap of $195.09 Billion USD reflects its position as one of the world's leading companies listed on NYSE. This historical data shows how Abbott Laboratories's market value has evolved, providing insights into its growth trajectory and market performance.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2025 | $198.16 Billion | -4.31% |
| 2024 | $207.08 Billion | +6.83% |
| 2023 | $193.83 Billion | -14.97% |
| 2022 | $227.97 Billion | -1.71% |
| 2021 | $231.94 Billion | +25.54% |
| 2020 | $184.75 Billion | +31.50% |
| 2019 | $140.49 Billion | +20.98% |
| 2018 | $116.13 Billion | +31.60% |
| 2017 | $88.24 Billion | +30.66% |
| 2016 | $67.54 Billion | -9.37% |
| 2015 | $74.52 Billion | +12.11% |
| 2014 | $66.47 Billion | +22.47% |
| 2013 | $54.27 Billion | +13.99% |
| 2012 | $47.61 Billion | +32.25% |
| 2011 | $36.00 Billion | +6.67% |
| 2010 | $33.75 Billion | +1.56% |
| 2009 | $33.23 Billion | -2.89% |
| 2008 | $34.22 Billion | +3.44% |
| 2007 | $33.08 Billion | +22.69% |
| 2006 | $26.97 Billion | +2.23% |
| 2005 | $26.38 Billion | +7.60% |
| 2004 | $24.51 Billion | +17.34% |
| 2003 | $20.89 Billion | -14.88% |
| 2002 | $24.54 Billion | +2.03% |
| 2001 | $24.06 Billion | +3.59% |
| 2000 | $23.22 Billion | +8.15% |
| 1999 | $21.47 Billion | +7.10% |
| 1998 | $20.05 Billion | +47.17% |
| 1997 | $13.62 Billion | +23.66% |
| 1996 | $11.02 Billion | +30.61% |
| 1995 | $8.43 Billion | +34.99% |
| 1994 | $6.25 Billion | +14.99% |
| 1993 | $5.43 Billion | -8.04% |
| 1992 | $5.91 Billion | -0.97% |
| 1991 | $5.97 Billion | +54.39% |
| 1990 | $3.86 Billion | +32.60% |
| 1989 | $2.91 Billion | +40.79% |
| 1988 | $2.07 Billion | -21.21% |
| 1987 | $2.63 Billion | +24.63% |
| 1986 | $2.11 Billion | +56.70% |
| 1985 | $1.35 Billion | +67.52% |
| 1984 | $803.05 Million | -- |
Data sources: Market capitalizations are derived from Abbott Laboratories's annual reports, filings, and other publicly available data sources.